autoimmune disease

Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Fri, 11/15/19 - 11:14 am
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease
J&J's Remicade losing ground in Quebec health plan despite court victory
Yahoo/Reuters
Wed, 11/13/19 - 09:59 am
JNJ
Canada
Quebec
Remicade
autoimmune disease
Pandion, Astellas sign $900m deal for pancreas-targeted immunomodulators
Pharmaceutical Business Review
Thu, 10/31/19 - 11:03 am
Astellas
Pandion Therapeutics
immunomodulators
autoimmune disease
Pancreas
CAR-T cells as 'bait' show promise in autoimmune disease
Fierce Biotech
Mon, 10/14/19 - 09:52 am
CAR-T
autoimmune disease
Oxford spinout MiroBio bags £27M for autoimmune R&D
Fierce Biotech
Mon, 10/7/19 - 11:20 am
MiroBio
autoimmune disease
R&D
Cabaletta Bio Files for $100 Million IPO
CP Wire
Wed, 10/2/19 - 10:50 am
Cabaletta Bio
IPOs
autoimmune disease
DSG3-CAART
pemphigus vulgaris
Promising autoimmune biotech gets $40 million as celiac drug is pushed to clinic
Endpoints
Wed, 09/11/19 - 10:30 am
celiac disease
autoimmune disease
Anokion
Kanyos Bio
Kan-101
FDA approves Rituxan biosimilar
Beckers Hospital Review
Tue, 07/23/19 - 07:40 pm
Pfizer
biosimilars
FDA
Ruxience
cancer
autoimmune disease
Genentech
Alexion's cash cow Soliris just got fatter as FDA greenlights another blockbuster indication
Endpoints
Fri, 06/28/19 - 12:36 pm
Alexion
Soliris
FDA
autoimmune disease
NMOSD
AstraZeneca spinout Viela Bio pockets $75M on its way to BLA for autoimmune drug
Endpoints
Mon, 06/17/19 - 12:21 pm
Viela Bio
AstraZeneca
autoimmune disease
Genentech lines up a new autoimmune R&D alliance on a 'potentially transformative' tech
Endpoints
Thu, 05/16/19 - 10:03 am
Parvus Therapeutics
Genentech
drug discovery
autoimmune disease
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
Fierce Biotech
Thu, 04/25/19 - 10:37 am
Salix
Mitsubishi Tanabe Pharma
amiselimod
Bausch Health
autoimmune disease
ulcerative colitis
Celgene taps Exscientia’s AI drug discovery tech for 3 new programs
Fierce Biotech
Thu, 03/21/19 - 10:01 am
Celgene
Exscientia
artificial intelligence
oncology
autoimmune disease
drug discovery
Principia, AbbVie walk away from 2017 partnership for inflammatory, autoimmune drugs
Endpoints
Mon, 03/11/19 - 10:38 am
AbbVie
Principia Biopharma
inflammatory diseases
autoimmune disease
Lilly, Aduro Biotech in Immunotherapy Alliance
Contract Pharma
Thu, 12/20/18 - 11:46 am
Eli Lilly
Aduro BioTech
autoimmune disease
drug development
Johnson & Johnson drops OSE’s rheumatoid arthritis drug
Fierce Biotech
Fri, 11/2/18 - 07:56 pm
JNJ
OSE Immuotherapeutics
FR104
autoimmune disease
rheumatoid arthritis
AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work
Endpoints
Mon, 08/20/18 - 10:11 am
IPOs
Principia Biopharma
Sanofi
AbbVie
PRN1008
autoimmune disease
Bristol-Myers Squibb signs new development agreement for autoimmune disorders treatments
GoinPharma
Wed, 07/25/18 - 09:27 am
autoimmune disease
Bristol-Myers Squibb
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M
Xconomy
Mon, 07/23/18 - 10:24 pm
Sangamo BioSciences
M&A
TxCell
autoimmune disease
cell therapy
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease

Pages